Starpharma Holdings Limited announced that as part of Starpharma's ongoing board renewal process non- executive director, Ms Zita Peach will not seek re-election at the upcoming Annual General Meeting and will retire at the conclusion of the meeting on 29 November 2022. Ms Peach has been a non-executive director of Starpharma for 11 years, and her retirement is part of the Board's renewal process and follows a transition period after the appointment of Dr Jeff Davies as an independent non-executive director with extensive healthcare experience on 1 April 2022. Dr Davies is a former CSL executive, with over 35 years of biopharmaceutical experience, holding senior executive roles at CSL, including Executive Vice President & General Manager at CSL for the Asia-Pacific region, and Global Head of Plasma Product Research and Development at CSL-Behring, Switzerland.